合計 50 件の最近のインサイダー取引記録が記録されています Monte Rosa Therapeutics, Inc. (GLUE), 内訳は 29 件の買い および 20 件の売り. インサイダー買い総額は $8.8M インサイダー売り総額は $11.95M.
最近活動のある主要インサイダーには Dunn Edmund, Warmuth Markus, Janku Filip. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — GLUE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-04 |
Dunn Edmund |
Principal Accounting Officer |
情報に基づく売り |
139 |
$17.96 |
$2.5K |
22,554 |
| 2026-03-02 |
Dunn Edmund |
Principal Accounting Officer |
オプション行使（売却） |
536 |
$13.41 |
$7.19K |
- |
| 2026-03-02 |
Warmuth Markus |
President & CEO |
情報に基づく売り |
5,466 |
$17.92 |
$97.97K |
613,471 |
| 2026-02-27 |
Dunn Edmund |
Principal Accounting Officer |
オプション行使（売却） |
25,164 |
$13.41 |
$337.45K |
536 |
| 2026-02-23 |
Janku Filip |
Chief Medical Officer |
情報に基づく売り |
9,189 |
$19.50 |
$179.16K |
65,837 |
| 2026-01-07 |
Warmuth Markus |
President & CEO |
情報に基づく売り |
309 |
$24.57 |
$7.59K |
618,937 |
| 2026-01-05 |
Warmuth Markus |
President & CEO |
情報に基づく売り |
10,135 |
$15.17 |
$153.75K |
624,403 |
| 2026-01-05 |
Townson Sharon |
Chief Scientific Officer |
情報に基づく売り |
3,155 |
$15.17 |
$47.86K |
67,845 |
| 2026-01-05 |
Janku Filip |
Chief Medical Officer |
情報に基づく売り |
3,155 |
$15.17 |
$47.86K |
75,026 |
| 2026-01-05 |
Nickson Philip |
Chief Business & Legal Officer |
情報に基づく売り |
3,155 |
$15.17 |
$47.86K |
60,845 |
| 2026-01-05 |
Dunn Edmund |
Principal Accounting Officer |
情報に基づく売り |
1,039 |
$15.17 |
$15.76K |
22,693 |
| 2026-01-05 |
Champoux Jennifer |
Chief Operating Officer |
情報に基づく売り |
2,629 |
$15.17 |
$39.88K |
62,371 |
| 2026-01-02 |
Warmuth Markus |
President & CEO |
RSU 付与（制限付株式） |
406,000 |
$15.31 |
$6.22M |
406,000 |
| 2026-01-02 |
Townson Sharon |
Chief Scientific Officer |
RSU 付与（制限付株式） |
35,000 |
- |
- |
71,000 |
| 2026-01-02 |
Janku Filip |
Chief Medical Officer |
RSU 付与（制限付株式） |
31,000 |
- |
- |
78,181 |
| 2026-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
RSU 付与（制限付株式） |
28,000 |
- |
- |
64,000 |
| 2026-01-02 |
Champoux Jennifer |
Chief Operating Officer |
RSU 付与（制限付株式） |
35,000 |
- |
- |
65,000 |
| 2025-06-13 |
Schiff Andrew N |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Behbahani Ali |
10 Percent Owner |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Manning Anthony M. |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Siu Christine |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Blackwell Kimberly |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Skvarka Jan |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Hughes Eric A |
Director |
RSU 付与（制限付株式） |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-03 |
Dunn Edmund |
Principal Accounting Officer |
情報に基づく売り |
2,062 |
$4.45 |
$9.17K |
23,732 |
| 2025-03-24 |
Leo Chandra P. |
Director |
情報に基づく買い |
10,000 |
$5.84 |
$58.38K |
10,000 |
| 2025-01-02 |
Warmuth Markus |
President & CEO |
RSU 付与（制限付株式） |
128,000 |
- |
- |
544,538 |
| 2025-01-02 |
Townson Sharon |
Chief Scientific Officer |
RSU 付与（制限付株式） |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Janku Filip |
Chief Medical Officer |
RSU 付与（制限付株式） |
36,000 |
- |
- |
45,189 |
| 2025-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
RSU 付与（制限付株式） |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Dunn Edmund |
Principal Accounting Officer |
RSU 付与（制限付株式） |
11,850 |
- |
- |
25,794 |
| 2025-01-02 |
Champoux Jennifer |
Chief Operating Officer |
RSU 付与（制限付株式） |
30,000 |
- |
- |
30,000 |
| 2024-12-11 |
Hughes Eric A |
Officer |
不明 |
- |
- |
- |
- |
| 2024-12-11 |
Hughes Eric A |
Director |
RSU 付与（制限付株式） |
44,200 |
$8.51 |
$376.14K |
44,200 |
| 2024-10-29 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
15,600 |
$9.41 |
$146.79K |
1,573,453 |
| 2024-10-28 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
その他（売り） |
5,454 |
- |
- |
- |
| 2024-09-20 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
1,132,566 |
$6.53 |
$7.4M |
5,099,336 |
| 2024-09-13 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
9,269 |
$6.16 |
$57.1K |
6,231,902 |
| 2024-09-13 |
Janku Filip |
Chief Medical Officer |
RSU 付与（制限付株式） |
30,000 |
$7.56 |
$226.8K |
30,000 |
| 2024-09-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
16,047 |
$6.00 |
$96.31K |
6,241,171 |
| 2024-09-11 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
541,897 |
$6.00 |
$3.25M |
6,257,218 |
| 2024-07-05 |
Dunn Edmund |
Principal Accounting Officer |
情報に基づく売り |
1,610 |
$3.83 |
$6.17K |
13,944 |
| 2024-06-12 |
Schiff Andrew N |
Director |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Behbahani Ali |
10 Percent Owner |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Manning Anthony M. |
Director |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Siu Christine |
Director |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Blackwell Kimberly |
Director |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Skvarka Jan |
Director |
RSU 付与（制限付株式） |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-03 |
Townson Sharon |
Chief Scientific Officer |
RSU 付与（制限付株式） |
40,000 |
$3.98 |
$159.2K |
40,000 |
| 2024-06-03 |
Nickson Philip |
Chief Business & Legal Officer |
RSU 付与（制限付株式） |
40,000 |
$3.98 |
$159.2K |
40,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
